Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis

Journal of the Medical Association of Thailand

Volumn 87, Issue SUPPL. 2, 2004, Pages

  Wannanukul, Siriwan ^a   Chiabunkana, Jutamas ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Hydrocortisone; Infantile; Ketoconazole; Seborrheic dermatitis

Indexed keywords

HYDROCORTISONE; KETOCONAZOLE;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; ERYTHEMA; FEMALE; FOLLICULITIS; HUMAN; INFANT; MALE; PRESCHOOL CHILD; RASH; SEBORRHEIC DERMATITIS; TREATMENT OUTCOME; XEROSIS;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; DERMATITIS, SEBORRHEIC; FEMALE; HUMANS; HYDROCORTISONE; INFANT; KETOCONAZOLE; MALE; OINTMENTS; TREATMENT OUTCOME;

EID: 22744432326     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Faergemann J, Jones TC, Hettler O, Loria Y. Pityrosporum ovale (Malassezia furfur) as the causative agents of seborrhoeic dermatitis: new treatment options. Br J Dermatol 1996; 134: S12-5.
2. Janniger CK. Infantile seborrheic dermatitis: An approach to cradle cap. Cutis 1993; 51: 233-5.
3. Rajka G. Infantile seborrheic dermatitis. In: Harper J, Orange A, Prose N, editor. Textbook of pediatric dermatology. Oxford. Black well Science 2000: 255-9.
4. Ljubojevic S, Skerlev M, Lipozencic J, Basta - Juzbasic A. The role of Malassezia furfur in dermatology. Clin Dermatol 2002; 20: 179-82.
5. Tollesson A, Frithz A, Stenlund K. Malassezia furfur in infantile seborrheic dermatitis. Pediatr Dermatol 1997; 14: 423-5.
6. Broberg A, Faergemann J. Infantile seborrheic dermatitis and Pityrosporum ovale. J Dermatol 1994; 21: 334-40.
7. Ruiz-Maldonado R, Lopez-Matinez R, Pezez Chavarria EP, Rocic Castanon LR, Tamayo L. Pityrosporum ovale in infantile seborrheic dermatitis. Pediatr Dermatol 1989; 6: 16-20.
8. Taieb A, Legrain V, Palmier C, Lejeans, Six M, Maleville J. Topical ketoconazole for infantile seborrhoeic dermatitis. Dermatologica 1990; 181: 26-32.
9. Brodell RT, Patel S, Venglarcik JS, Moses D, Gemmel D. The safety of ketoconazole shampoo for infantile seborrheic dermatitis. Pediatr Dermatol 1998; 15: 406-7.
10. Faergemann J. Seborrheic dermatitis and Pityrosporum orbiculare: treatment of the seborrheic dermatitis of the scalp with miconazone- hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol 1986; 114: 695-700.
11. Skinner RB, Noah PW, Taylor RM, Zanolli MD, West S, Guin JP, et al. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol 1985; 2: 852-6.
12. Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrheic dermatitis to ketoconazole. Br J Dermatol 1984; 111: 603-7.
13. Stratigos JD, Antoniou C, Katsambas A, Bohler K, Fritsch P, Schmolz A, et al. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis: a double-blind comparative study. J Am Acad Dermatol 1988; 19: 850-3.
14. Baysal V, Yildirim M, Ozcanli C, Ceyhan AM. Itraconazole in the treatment of seborrheic dermatitis:a new treatment modality. Int J Dermatol 2004; 43: 63-6.
15. Sei Y, Hamaguchi T, Ninomiya J, Nakabayashi A, Takiuchi I. Seborrheic dermatitis: Treatment with antimycotic agent. Br J Dermatol 1989; 120: 359-62.
16. Pierard-Franchimont C, Pierard GE, Arrese JE, De Doncker P. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology 2001; 202: 171-6.
17. Ortonne JP, Lacour JP, Vitetta A, Le Fichoux Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. Dermatology 1992; 184: 275-80.
18. Pierard-Franchimont C, Pierard GE. A double-blind placebo-controlled study of ketoconazole and desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology 2002; 204: 344-7.
19. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology 1998; 116: 140-7.
20. Van Cutsem J, Van Gerven F, Cauwenbergh G, Odds F, Janssen PA. The anti-inflammatory effect of ketoconazole: A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea-pigs. J Am Acad Dermatol 1991; 25: 257-6.
21. Beetens JR, Loots W, Somers Y, Conene MC, De Clerck F. Ketoconazole inhibits the biosynthesis of leukotriens in vitro and in vivo. Biochem Pharmacol 1986; 35: 883-91.
22. Gupta AK, Kohli Y, Li A, Faergemann J, Summerbell RC. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol 2000; 142: 758-65.
23. Bergbrant IM, Andersson B, Faergemann J. Cell-mediated immunity to Malassezia furfur in patients with seborrhoeic dermatitis and pityriasis versicolor. Clin Expl Dermatol 1999; 24: 402-06.
24. Faergemann J, Bergbrant IM, Dohse M, Scott A, Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001; 144: 549-56.
25. Watanabe S, Kano R, Sato H, Nakammura Y, Hasegawa A. The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 2001; 116: 769-73.